Guardant Health Statistics
Total Valuation
Guardant Health has a market cap or net worth of $12.69 billion. The enterprise value is $13.26 billion.
Important Dates
The last earnings date was Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Guardant Health has 132.60 million shares outstanding. The number of shares has increased by 3.20% in one year.
| Current Share Class | 132.60M |
| Shares Outstanding | 132.60M |
| Shares Change (YoY) | +3.20% |
| Shares Change (QoQ) | +2.03% |
| Owned by Insiders (%) | 4.09% |
| Owned by Institutions (%) | 99.76% |
| Float | 127.15M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.75 |
| Forward PS | 9.11 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 12.28 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.68
| Current Ratio | 4.68 |
| Quick Ratio | 4.25 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -100.29 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -17.13% |
| Return on Invested Capital (ROIC) | -21.88% |
| Return on Capital Employed (ROCE) | -27.51% |
| Weighted Average Cost of Capital (WACC) | 11.01% |
| Revenue Per Employee | $431,051 |
| Profits Per Employee | -$172,862 |
| Employee Count | 2,506 |
| Asset Turnover | 0.66 |
| Inventory Turnover | 4.71 |
Taxes
| Income Tax | -1.18M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +140.82% in the last 52 weeks. The beta is 1.49, so Guardant Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.49 |
| 52-Week Price Change | +140.82% |
| 50-Day Moving Average | 88.68 |
| 200-Day Moving Average | 84.72 |
| Relative Strength Index (RSI) | 60.66 |
| Average Volume (20 Days) | 2,038,344 |
Short Selling Information
The latest short interest is 11.64 million, so 8.78% of the outstanding shares have been sold short.
| Short Interest | 11.64M |
| Short Previous Month | 13.70M |
| Short % of Shares Out | 8.78% |
| Short % of Float | 9.16% |
| Short Ratio (days to cover) | 5.67 |
Income Statement
In the last 12 months, Guardant Health had revenue of $1.08 billion and -$433.19 million in losses. Loss per share was -$3.40.
| Revenue | 1.08B |
| Gross Profit | 701.01M |
| Operating Income | -446.61M |
| Pretax Income | -434.37M |
| Net Income | -433.19M |
| EBITDA | -407.67M |
| EBIT | -446.61M |
| Loss Per Share | -$3.40 |
Full Income StatementBalance Sheet
The company has $1.10 billion in cash and $1.68 billion in debt, with a net cash position of -$573.77 million or -$4.33 per share.
| Cash & Cash Equivalents | 1.10B |
| Total Debt | 1.68B |
| Net Cash | -573.77M |
| Net Cash Per Share | -$4.33 |
| Equity (Book Value) | -181.07M |
| Book Value Per Share | -1.38 |
| Working Capital | 1.08B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$187.69 million and capital expenditures -$49.43 million, giving a free cash flow of -$237.12 million.
| Operating Cash Flow | -187.69M |
| Capital Expenditures | -49.43M |
| Depreciation & Amortization | 38.94M |
| Net Borrowing | 402.50M |
| Free Cash Flow | -237.12M |
| FCF Per Share | -$1.79 |
Full Cash Flow StatementMargins
Gross margin is 64.90%, with operating and profit margins of -41.34% and -40.10%.
| Gross Margin | 64.90% |
| Operating Margin | -41.34% |
| Pretax Margin | -40.21% |
| Profit Margin | -40.10% |
| EBITDA Margin | -37.74% |
| EBIT Margin | -41.34% |
| FCF Margin | n/a |
Dividends & Yields
Guardant Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.20% |
| Shareholder Yield | -3.20% |
| Earnings Yield | -3.41% |
| FCF Yield | -1.87% |
Dividend DetailsAnalyst Forecast
The average price target for Guardant Health is $120.58, which is 26.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $120.58 |
| Price Target Difference | 26.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 19 |
| Revenue Growth Forecast (5Y) | 22.97% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |
